OA12316A - 3-Aminoquinazolin-2,4-dione antibacterial agents. - Google Patents
3-Aminoquinazolin-2,4-dione antibacterial agents. Download PDFInfo
- Publication number
- OA12316A OA12316A OA1200200210A OA1200200210A OA12316A OA 12316 A OA12316 A OA 12316A OA 1200200210 A OA1200200210 A OA 1200200210A OA 1200200210 A OA1200200210 A OA 1200200210A OA 12316 A OA12316 A OA 12316A
- Authority
- OA
- OAPI
- Prior art keywords
- amino
- dione
- cyclopropyl
- fluoro
- quinazoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Paper (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17825200P | 2000-01-24 | 2000-01-24 | |
US24126700P | 2000-10-18 | 2000-10-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
OA12316A true OA12316A (en) | 2006-05-15 |
Family
ID=26874138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA1200200210A OA12316A (en) | 2000-01-24 | 2000-12-12 | 3-Aminoquinazolin-2,4-dione antibacterial agents. |
Country Status (38)
Country | Link |
---|---|
US (2) | US7094780B1 (fr) |
EP (1) | EP1255739B1 (fr) |
JP (1) | JP4811978B2 (fr) |
KR (1) | KR20020067701A (fr) |
CN (1) | CN1425008A (fr) |
AP (1) | AP2002002603A0 (fr) |
AR (1) | AR030186A1 (fr) |
AT (1) | ATE398110T1 (fr) |
AU (1) | AU783078B2 (fr) |
BG (1) | BG107023A (fr) |
BR (1) | BR0017010A (fr) |
CA (1) | CA2393802C (fr) |
CO (1) | CO5320600A1 (fr) |
CR (1) | CR6709A (fr) |
DE (1) | DE60039194D1 (fr) |
EA (1) | EA005585B1 (fr) |
EE (1) | EE200200412A (fr) |
ES (1) | ES2304992T3 (fr) |
GE (1) | GEP20053429B (fr) |
HK (1) | HK1054237A1 (fr) |
HN (1) | HN2001000009A (fr) |
HR (1) | HRP20020696A2 (fr) |
HU (1) | HUP0204101A3 (fr) |
IL (1) | IL150393A0 (fr) |
IS (1) | IS6448A (fr) |
MA (1) | MA26866A1 (fr) |
MX (1) | MXPA02005989A (fr) |
NO (1) | NO20023516D0 (fr) |
OA (1) | OA12316A (fr) |
PA (1) | PA8510101A1 (fr) |
PE (1) | PE20011060A1 (fr) |
PL (1) | PL356837A1 (fr) |
SK (1) | SK10572002A3 (fr) |
SV (1) | SV2001000288A (fr) |
TN (1) | TNSN01011A1 (fr) |
UY (1) | UY26551A1 (fr) |
WO (1) | WO2001053273A1 (fr) |
YU (1) | YU55902A (fr) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0100051A3 (en) | 1997-09-15 | 2002-08-28 | Procter & Gamble | Antimicrobial quinolones, their compositions and uses |
ATE315038T1 (de) | 2001-05-30 | 2006-02-15 | Warner Lambert Co | Antibakterielle mittel |
CA2446963A1 (fr) * | 2001-06-19 | 2002-12-27 | Warner-Lambert Company Llc | Agents antibacteriens |
US6900224B2 (en) * | 2002-07-31 | 2005-05-31 | The Procter & Gamble Company | Antimicrobial quinolones, their compositions and uses |
WO2005026153A1 (fr) * | 2003-09-12 | 2005-03-24 | Warner-Lambert Company Llc | Quinazoline-2,4-diones a titre d'agents antibacteriens |
BRPI0414319A (pt) * | 2003-09-12 | 2006-11-07 | Warner Lambert Co | agentes antibacterianos de quinolona |
CA2546339A1 (fr) * | 2003-11-18 | 2005-06-02 | Warner-Lambert Company Llc | Derives antibacteriens d'aminoquinazolidinedione |
WO2006019965A2 (fr) * | 2004-07-16 | 2006-02-23 | Takeda San Diego, Inc. | Inhibiteurs de la dipeptidyl peptidase |
GB0416730D0 (en) | 2004-07-27 | 2004-09-01 | Novartis Ag | Organic compounds |
ES2332529T3 (es) * | 2005-01-26 | 2010-02-08 | F. Hoffmann-La Roche Ag | Derivados de fenil-metanona y su empleo como inhibidores del transportador 1 de glicina. |
GB0507298D0 (en) | 2005-04-11 | 2005-05-18 | Novartis Ag | Organic compounds |
US7977346B2 (en) | 2006-01-17 | 2011-07-12 | Guoqing Paul Chen | Spiro compounds and methods of use |
JP2009531418A (ja) | 2006-03-28 | 2009-09-03 | ザ プロクター アンド ギャンブル カンパニー | キノロン中間体調製のためのカップリング方法 |
WO2007110834A2 (fr) | 2006-03-28 | 2007-10-04 | The Procter & Gamble Company | Malates et formes polymorphes de l'acide (3s,5s)-7-[3-amino-5-méthyl-pipéridinyl]-1-cyclopropyl-1,4-dihydro-8-méthoxy-4-oxo-3-quinoléine-carboxylique |
US20080139574A1 (en) | 2006-11-30 | 2008-06-12 | Cadila Healthcare Limited | Novel quinoline derivatives |
US8404696B2 (en) * | 2008-01-30 | 2013-03-26 | Shin Poong Pharmaceutical Co., Ltd. | Quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same |
WO2011031745A1 (fr) | 2009-09-09 | 2011-03-17 | Achaogen, Inc. | Analogues de fluoroquinolone antibactériens |
US8754114B2 (en) | 2010-12-22 | 2014-06-17 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3 |
AU2012229997B2 (en) | 2011-03-15 | 2016-04-14 | Lawrence Livermore National Security, Llc | Tricyclic gyrase inhibitors |
AU2012357296B2 (en) * | 2011-12-21 | 2017-04-13 | Jiangsu Hengrui Medicine Co., Ltd. | Pyrrole six-membered heteroaryl ring derivative, preparation method therefor, and medicinal uses thereof |
ES2704744T3 (es) | 2012-06-13 | 2019-03-19 | Incyte Holdings Corp | Compuestos tricíclicos sustituidos como inhibidores de FGFR |
WO2014026125A1 (fr) | 2012-08-10 | 2014-02-13 | Incyte Corporation | Dérivés de pyrazine en tant qu'inhibiteurs de fgfr |
CN105189505B (zh) | 2012-09-12 | 2019-03-22 | 默克夏普&多梅有限公司 | 用作抗菌剂的三环促旋酶抑制剂 |
US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
CN109776525B (zh) | 2013-04-19 | 2022-01-21 | 因赛特控股公司 | 作为fgfr抑制剂的双环杂环 |
US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
US9580423B2 (en) | 2015-02-20 | 2017-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
AU2016219822B2 (en) | 2015-02-20 | 2020-07-09 | Incyte Holdings Corporation | Bicyclic heterocycles as FGFR inhibitors |
CN108530448A (zh) * | 2017-03-02 | 2018-09-14 | 浙江司太立制药股份有限公司 | 含有碱性氮杂螺环片段的苯并噻嗪-4-酮类化合物及其制备方法 |
AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
BR112020022392A2 (pt) | 2018-05-04 | 2021-02-02 | Incyte Corporation | formas sólidas de um inibidor de fgfr e processos para preparação das mesmas |
MX2020011639A (es) | 2018-05-04 | 2021-02-15 | Incyte Corp | Sales de un inhibidor de receptores de factor de crecimiento de fibroblastos (fgfr). |
CN111620866A (zh) * | 2019-02-27 | 2020-09-04 | 南京药石科技股份有限公司 | 一种顺式-7,7-二氟-六氢-1H 吡咯并[3,4-c]吡啶衍生物及其制备方法 |
WO2020185532A1 (fr) | 2019-03-08 | 2020-09-17 | Incyte Corporation | Méthodes de traitement du cancer au moyen d'un inhibiteur de fgfr |
US11591329B2 (en) | 2019-07-09 | 2023-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
IL291901A (en) | 2019-10-14 | 2022-06-01 | Incyte Corp | Bicyclyl heterocycles as fgr suppressors |
WO2021076728A1 (fr) | 2019-10-16 | 2021-04-22 | Incyte Corporation | Hétérocycles bicycliques en tant qu'inhibiteurs de fgfr |
WO2021113479A1 (fr) | 2019-12-04 | 2021-06-10 | Incyte Corporation | Hétérocycles tricycliques en tant qu'inhibiteurs de fgfr |
KR20220131900A (ko) | 2019-12-04 | 2022-09-29 | 인사이트 코포레이션 | Fgfr 억제제의 유도체 |
WO2021146424A1 (fr) | 2020-01-15 | 2021-07-22 | Incyte Corporation | Hétérocycles bicycliques en tant qu'inhibiteurs de fgfr |
CN111499513B (zh) * | 2020-04-24 | 2023-03-14 | 上海毕得医药科技股份有限公司 | 一种2,3,4,5-四溴苯甲酸酯的合成方法 |
CA3215903A1 (fr) | 2021-04-12 | 2022-10-20 | Incyte Corporation | Polytherapie comprenant un inhibiteur de fgfr et un agent de ciblage de nectine-4 |
EP4352059A1 (fr) | 2021-06-09 | 2024-04-17 | Incyte Corporation | Hétérocycles tricycliques en tant qu'inhibiteurs de fgfr |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1068263B (fr) * | 1959-11-05 | |||
FR1203542A (fr) * | 1958-02-25 | 1960-01-19 | Rhone Poulenc Sa | Nouveaux dérivés de la phénothiazine comportant en position 10 une chaîne pipérazinique et leurs procédés de préparation |
DE3068648D1 (de) * | 1980-03-10 | 1984-08-30 | Berri Balzac | Derivatives of 3-amino-(1h,3h)-2,4-quinazolin-diones |
GB2097784A (en) * | 1981-04-28 | 1982-11-10 | Davidson Dr John Stirton | Dihydrobenzotriazepine diones; aminoquinazoline diones |
WO1994014809A1 (fr) | 1992-12-23 | 1994-07-07 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Derives anneles d'uracile |
WO1998018781A2 (fr) | 1996-10-28 | 1998-05-07 | Versicor, Inc. | Banques combinatoires de 2,4-pyrimidinediones fusionnes et 2,4-pyrimidinediones fusionnes actifs biologiquement |
ATE239000T1 (de) | 1997-10-28 | 2003-05-15 | Warner Lambert Co | 7-substituierte chinazolin-2,4-dionen verwendbar als antibakterielle mittel |
DE69939168D1 (de) * | 1998-05-26 | 2008-09-04 | Warner Lambert Co | Bicyclische pyrimidine und bicyclische 3,4-dihydropyrimidine als inhibitoren der zellvermehrung |
DK1137640T3 (da) * | 1998-12-11 | 2006-02-06 | Hoffmann La Roche | Cykliske hydrazinderivater som TNF-alfa-inhibitorer |
-
2000
- 2000-12-12 EP EP00984246A patent/EP1255739B1/fr not_active Expired - Lifetime
- 2000-12-12 ES ES00984246T patent/ES2304992T3/es not_active Expired - Lifetime
- 2000-12-12 AP APAP/P/2002/002603A patent/AP2002002603A0/en unknown
- 2000-12-12 GE GE4912A patent/GEP20053429B/en unknown
- 2000-12-12 DE DE60039194T patent/DE60039194D1/de not_active Expired - Lifetime
- 2000-12-12 MX MXPA02005989A patent/MXPA02005989A/es active IP Right Grant
- 2000-12-12 IL IL15039300A patent/IL150393A0/xx unknown
- 2000-12-12 AU AU20899/01A patent/AU783078B2/en not_active Ceased
- 2000-12-12 JP JP2001553275A patent/JP4811978B2/ja not_active Expired - Fee Related
- 2000-12-12 AT AT00984246T patent/ATE398110T1/de not_active IP Right Cessation
- 2000-12-12 CA CA2393802A patent/CA2393802C/fr not_active Expired - Fee Related
- 2000-12-12 OA OA1200200210A patent/OA12316A/en unknown
- 2000-12-12 WO PCT/US2000/033656 patent/WO2001053273A1/fr active Search and Examination
- 2000-12-12 PL PL00356837A patent/PL356837A1/xx not_active Application Discontinuation
- 2000-12-12 EA EA200200661A patent/EA005585B1/ru not_active IP Right Cessation
- 2000-12-12 US US10/182,221 patent/US7094780B1/en not_active Expired - Fee Related
- 2000-12-12 BR BR0017010-0A patent/BR0017010A/pt not_active Application Discontinuation
- 2000-12-12 SK SK1057-2002A patent/SK10572002A3/sk unknown
- 2000-12-12 YU YU55902A patent/YU55902A/sh unknown
- 2000-12-12 EE EEP200200412A patent/EE200200412A/xx unknown
- 2000-12-12 HU HU0204101A patent/HUP0204101A3/hu unknown
- 2000-12-12 KR KR1020027009515A patent/KR20020067701A/ko not_active Application Discontinuation
- 2000-12-12 CN CN00818578A patent/CN1425008A/zh active Pending
-
2001
- 2001-01-19 PA PA20018510101A patent/PA8510101A1/es unknown
- 2001-01-22 HN HN2001000009A patent/HN2001000009A/es unknown
- 2001-01-22 TN TNTNSN01011A patent/TNSN01011A1/fr unknown
- 2001-01-22 SV SV2001000288A patent/SV2001000288A/es not_active Application Discontinuation
- 2001-01-22 UY UY26551A patent/UY26551A1/es not_active Application Discontinuation
- 2001-01-22 CO CO01004183A patent/CO5320600A1/es not_active Application Discontinuation
- 2001-01-22 PE PE2001000066A patent/PE20011060A1/es not_active Application Discontinuation
- 2001-01-23 AR ARP010100278A patent/AR030186A1/es unknown
-
2002
- 2002-06-27 IS IS6448A patent/IS6448A/is unknown
- 2002-07-19 CR CR6709A patent/CR6709A/es not_active Application Discontinuation
- 2002-07-22 MA MA26734A patent/MA26866A1/fr unknown
- 2002-07-23 NO NO20023516A patent/NO20023516D0/no not_active Application Discontinuation
- 2002-08-22 BG BG107023A patent/BG107023A/xx unknown
- 2002-08-23 HR HR20020696A patent/HRP20020696A2/hr not_active Application Discontinuation
-
2003
- 2003-09-11 HK HK03106519.6A patent/HK1054237A1/zh unknown
-
2006
- 2006-06-13 US US11/452,121 patent/US7582627B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
OA12316A (en) | 3-Aminoquinazolin-2,4-dione antibacterial agents. | |
JPH0819099B2 (ja) | アザビシクロキノロンカルボン酸化合物製造用中間体 | |
HU196986B (en) | Process for producing new naphtiridine- and quinoline-carboxylic acids of antibacterial activity and pharmaceutical compositions containing them | |
EP1028950B1 (fr) | Quinazolin-2,4-diones substituees en 7 utiles en tant qu'agents antibacteriens | |
EP3080131A1 (fr) | Composés imidazopyridazine utiles en tant que modulateurs de réponses à il-12, il-23 et/ou ifn | |
JP2003026574A (ja) | 抗バクテリア剤 | |
AU748749B2 (en) | Isoquinolones | |
NZ243214A (en) | 7-isoindolino-quinolone and naphthyridonecarboxylic acid derivatives and pharmaceutical compositions | |
CZ190393A3 (en) | Derivatives of 7-isoindolinylquinoline and 7-isoindolinylnaphthhydridone | |
JPS61243077A (ja) | 抗菌剤 | |
HU219581B (hu) | Új piridon-karbonsav-származékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek | |
EP0362759A1 (fr) | Acides pyridinonecarboxyliques | |
US20030114666A1 (en) | Antibacterial agents | |
WO1995021163A1 (fr) | Derive d'acide pyridonecarboxylique substitue par un groupe amino bicyclique, ester et sel de celui-ci, et amine bicyclique utilisee en tant qu'intermediaire pour celui-ci | |
EP0347851A1 (fr) | Acides quinolonecarboxyliques | |
US5605910A (en) | Quinolone-and naphthyridonecarboxylic acid derivatives | |
JPH037260A (ja) | 新規キノロン誘導体またはその塩及びこれを含有する抗菌剤 | |
JP3951136B2 (ja) | 新規ピリドンカルボン酸誘導体又はその塩並びに該物質を有効成分とする抗菌剤 | |
JP4009874B2 (ja) | 新規ピリドンカルボン酸誘導体又はその塩並びに該物質を有効成分とする抗菌剤 | |
WO1997031919A1 (fr) | Derives d'acide pyridonecarboxylique et leur intermediaires de synthese |